ALGERNON PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.11 CAD | -8.33% |
|
0.00% | +69.23% |
Chart calendar Algernon Pharmaceuticals Inc.
93166a5e1272b25746bdeeafc96bff42.PxigO70C1b4Cks2jogjBPNS8ukoBd6nkkp1qUh0XnjQ.cV-QY_xJh_hs_ODZ-EGtSr_N1gN7G-Cvq-ciGEc6-H9JK-MDjmmyym6lgA~95aad62ec35109327ce2e40a3933735a
Upcoming events on Algernon Pharmaceuticals Inc.
Past events on Algernon Pharmaceuticals Inc.
| 30/04/2024 05:16 am | Q2 2024 Earnings Release |
| 17/04/2024 01:30 am | Investor Meeting - Radius Research |
| 26/01/2024 04:02 am | Q1 2024 Earnings Release |
| 30/12/2023 04:09 am | Q4 2023 Earnings Release |
| 29/07/2023 01:57 am | Q3 2023 Earnings Release |
| 10/06/2023 11:35 pm | American Cough Conference |
| 02/05/2023 03:58 am | Q2 2023 Earnings Release |
| 24/04/2023 | Sequire Investor Summit |
| 04/04/2023 09:30 am | Investor Meeting - Radius Research |
| 21/02/2023 10:30 am | Investor Meeting - Radius Research |
| 16/02/2023 10:30 am | Investor Meeting - Radius Research |
| 31/01/2023 05:58 am | Q1 2023 Earnings Release |
| 26/11/2022 06:27 am | FY 2022 Earnings Release |
| 05/11/2022 11:30 pm | Wonderland Psychedelic Conference |
| 04/11/2022 10:30 pm | Wonderland Psychedelic Conference |
| 27/09/2022 | Business Update Call |
| 03/08/2022 04:37 pm | Phase 2 IPF and Chronic Cough Study Data American Cough Conference |
| 30/07/2022 12:28 am | Q3 2022 Earnings Release |
| 28/04/2022 05:45 am | Interim 2022 Earnings Release |
| 01/03/2022 02:30 am | Annual General Meeting |
Annual results
| Fiscal Period | August | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
Net income | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EPS CAD | Released Forecast Spread | -1,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 18/12/19 | 18/12/20 | 26/11/21 | 26/11/22 |
Quarterly results
| Fiscal Period | August | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
Net income Million CAD | Released Forecast Spread | -1,84 | ||||
|
EPS CAD | Released Forecast Spread | -0,28 | ||||
| Announcement Date | 27/04/22 | 29/07/22 | 26/11/22 | 30/01/23 | 01/05/23 |
More events
Past sector events for Algernon Pharmaceuticals Inc.
| Today | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:31 am | MACROGENICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:31 am | ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release |
| 09/05/2024 11:30 am | VERONA PHARMA PLC: Q1 2024 Earnings Release |
| 09/05/2024 10:30 am | ARGENX SE: Q1 2024 Earnings Release |
| 09/05/2024 | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 | PRIME MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 | SAB BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 | CABALETTA BIO, INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 | ALPINE IMMUNE SCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- AGN Stock
- Calendar Algernon Pharmaceuticals Inc.